Human < Human Epidermal growth factor Receptor 2 < Human Resources

Facettes :

List of bibliographic references indexed by Human Epidermal growth factor Receptor 2

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
000633 (2013)		AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
001379 (2010)		Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in HER2-Positive Metastatic Breast Cancer
001407 (2010)		Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=FranceBresilV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Human Epidermal growth factor Receptor 2" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Human Epidermal growth factor Receptor 2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    FranceBresilV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Human Epidermal growth factor Receptor 2
}}

---

This area was generated with Dilib version V0.6.01. Data generation: Wed Apr 1 17:49:02 2015. Site generation: Mon Mar 11 12:05:52 2024